Yan-Feng Zhou | Public Health | Best Researcher Award

Published on by Health Scientists

Dr. Yan-Feng Zhou | Public Health | Best Researcher Award

Associate professor | Guangxi Medical University | China

Yan-Feng Zhou is an Associate Professor at Guangxi Medical University and a leading epidemiologist specializing in chronic disease prevention and healthy aging. Their research integrates large population-based cohorts with multi-omics approaches to elucidate the environmental, psychosocial, and biological determinants of cardiovascular disease, cognitive decline, and age-related chronic conditions. Zhou has played a pivotal role in establishing and directing major longitudinal cohorts in China, creating essential platforms for the study of ethnic and regional disparities in aging health and chronic disease risk. Their work is widely recognized for bridging population epidemiology with molecular mechanisms, particularly in the investigation of metal exposure, epigenetic regulation, and the gut–brain axis in cognitive aging. Zhou’s research has been disseminated through leading international journals including JAMA Network Open, Diabetologia, Hypertension, and Age and Aging, reflecting strong academic impact and global visibility, with consistent citation of their contributions in the scientific literature. They have secured sustained competitive research support from national and regional funding agencies and actively collaborate with multidisciplinary teams spanning public health, clinical medicine, environmental sciences, and molecular biology. Beyond research productivity, Zhou is deeply committed to academic mentorship, fostering the development of emerging scientists in epidemiology and preventive medicine. Their translational work has informed risk assessment strategies and evidence-based approaches for chronic disease prevention, contributing to improved population health and public health policy. Through an integrated program that connects exposure science, omics biology, and longitudinal population research, Zhou continues to shape contemporary understanding of aging, environmental health, and chronic disease prevention with meaningful societal and scientific impact.

Profile: ORCID 

Publications

1. Gao, J.-L., Deng, H., Wang, G.-D., Deng, H.-L., Feng, D.-Y., Wu, S.-L., Chen, S.-H., & Zhou, Y.-F. (2025). Time-dependent association between progression of arterial stiffness and risk of incident chronic kidney disease: A cohort study in China.

2. Yuan, R., Tong, Z., Chen, J.-X., Wang, Y., & Zhou, Y.-F. (2024). Global burden of ischemic heart disease in adolescents and young adults, 1990–2019.

3. Zhou, Y.-F., Chen, S., Chen, J.-X., Chen, S., Wang, G., Pan, X.-F., Wu, S., & Pan, A. (2024). Cost-effectiveness of a workplace-based hypertension management program in real-world practice in the Kailuan Study.

4. Zhou, Y.-F., Song, X.-Y., Pan, A., & Koh, W.-P. (2023). Nutrition and healthy ageing in Asia: A systematic review.

5. Pan, A., Zhou, Y.-F., & Liu, G. (2023). Associations of clinical risk factors and novel biomarkers with age at onset of type 2 diabetes.

Mai Kadry | Global Health | Editorial Board Member

Published on by Health Scientists

Assist. Prof. Dr. Mai Kadry | Global Health | Editorial Board Member 

Research Scientist | National Research Center | Egypt

Mai O. Kadry is a distinguished researcher at the National Research Centre in Giza, Egypt, recognized for her multidisciplinary contributions across metabolomics, molecular oncology, nanomedicine, toxicology, and women’s health research. Her scientific portfolio reflects a sustained commitment to unraveling the biochemical and molecular mechanisms underpinning complex diseases, with a particular focus on metabolic disorders, cancer progression, reproductive toxicology, and innovative therapeutic strategies. Through a substantial body of peer-reviewed publications, she has advanced understanding of how metabolic signatures, genomic interactions, and molecular signaling pathways can be leveraged to improve disease diagnosis, treatment response, and therapeutic safety. Her work frequently integrates serum metabolomics, network pharmacology, lipidomics, nanostructure-based drug delivery, and experimental validation models, enabling a comprehensive systems-level view of disease processes. She has collaborated extensively with national and international scientists, contributing to multidisciplinary studies on phytotherapeutics for endocrine disorders, nanoscale interventions to mitigate chemotherapeutic toxicity, and molecular crosstalk driving drug resistance in cancer cells. Her authorship and citation footprint reflect broad scholarly engagement, while her active participation in multi-institutional teams has supported knowledge exchange and capacity building within the biomedical research community. Kadry’s investigations into natural product therapeutics, oxidative brain injury mechanisms, autophagy regulation, and emerging RNA-based biomarkers contribute to public health and precision medicine, offering insights with potential translational relevance to women’s health, oncology, toxicology, and environmental exposure science. Collectively, her work demonstrates a strong commitment to scientific innovation, interdisciplinary integration, and the societal importance of developing safer, more effective therapeutic approaches that align with global health priorities. She has 462 citations from 50 documents with an h-index of 12.

Profiles: Scopus | ORCID

Publications

1. Kadry, M., Author, A. A., Author, B. B., … (2025). Exploring the therapeutic potential of marjoram (Origanum majorana L.) in polycystic ovary syndrome: Insights from serum metabolomics, network pharmacology and experimental validation.

2. Kadry, M., & Author, A. A. (2025). Novel insights into SNORD-78 and miR-122-5P: The predicted diagnostic indexes of lung cancer—Drug-loaded liposome formulations competing methylcholanthrene-induced lung cancer.

3. Kadry, M., Author, A. A., Author, B. B., Author, C. C., & Author, D. D. (2025). Oxidative brain injury ascending from DMBA: Metabolomics and BRAF3/FKBR/A2m molecular signaling crosstalk.

4. Kadry, M., Author, A. A., Author, B. B., … (2025). Metabolomics integrated genomics approach: Understanding multidrug resistance phenotype in MCF-7 breast cancer cells exposed to doxorubicin and ABCA1/EGFR/PI3K/PTEN crosstalk.

5. Kadry, M., Author, A. A., & Author, B. B. (2025). Titanium nanostructure mitigating doxorubicin-induced testicular toxicity in rats via regulating major autophagy signaling pathways.

Mohamed Abouelkhair | Public Health | Best Researcher Award

Published on by Health Scientists

Prof. Mohamed Abouelkhair | Public Health | Best Researcher Award

Associate professor | Rowan University | United States

Dr. Mohamed Adel Salaheldin Abouelkhair, DVM, MS, PhD, DACVM (Virology and Immunology), is an Associate Professor of Virology and Clinical Immunology at the Shreiber School of Veterinary Medicine, Rowan University, New Jersey. He earned his Bachelor of Veterinary Science and Master of Science in Veterinary Infectious Diseases from the University of Sadat City, Egypt, followed by a PhD in Comparative and Experimental Medicine from the University of Tennessee, Knoxville, where he also completed his postdoctoral research. Dr. Abouelkhair’s research spans veterinary and comparative immunology, viral pathogenesis, infectious disease diagnostics, microbial vaccines, and host-pathogen interactions, with particular focus on immunological mechanisms in companion animals and translational models for human health. He has authored and co-authored numerous peer-reviewed publications, book chapters, and has contributed to advancing molecular diagnostics and immunological assays used in veterinary medicine. His scholarly impact is reflected in multiple prestigious honors, including the Peggy Cotter Award for Outstanding Early Career Researcher from the American Society for Microbiology (ASM), the ASM Future Leaders Mentorship Fellowship, the Zoetis Distinguished Veterinary Teacher Award nomination, and recognition at the University of Tennessee Research Foundation awards for a U.S. patent on Staphylococcus pseudintermedius virulence factors. Additionally, he has been awarded multiple Scholarships of Teaching and Learning (SoTL) projects and the Southeastern Conference (SEC) Visiting Faculty Travel Grant. Beyond research, Dr. Abouelkhair actively serves the scientific community as Chair of the American College of Veterinary Microbiologists Graduate Student Awards Committee and contributes as a reviewer and editorial board member for leading scientific journals in microbiology, immunology, and virology.

Profiles: Google Scholar | ORCID

Publications

1. Elaadli, H., Badr, Y., Raouf, M., Kania, S. A., Elsakhawy, O. K., Altaib, H., & Abouelkhair, M. A. (2025). Isolation and molecular characterization of three Staphylococcus pseudintermedius strains from dogs and humans in Egypt. Current Microbiology. Advance online publication.

2. Elsakhawy, O. K., & Abouelkhair, M. A. (2025). Genome mining reveals a sactipeptide biosynthetic cluster in Staphylococcus pseudintermedius.

3. Elsakhawy, O. K., Roozitalab, A., Abouelkhair, M. A., & Roux, S. (2025). Genome sequence of a bovine respiratory syncytial virus strain from a cow in Tennessee. Microbiology Resource Announcements.

4. Elsakhawy, O. K., Roozitalab, A., Abouelkhair, M. A., & Matthijnssens, J. (2025). Genome sequence of a Tetraparvovirus ungulate 1 strain from a cow in Tennessee, USA. Microbiology Resource Announcements.

5. Baker, E., Rich, S. M., Dennis, M., Miller, D., Su, C., Rosypal von Dohlen, A., Abouelkhair, M. A., Hamer, S. A., Jensen, A., & Gerhold, R. (2025). Pathology and parasitology of free-ranging coyotes from Tennessee and South Carolina.

Hai Phan Vu | Public Health | Innovative Research Award

Published on by Health Scientists

Dr. Hai Phan Vu | Public Health | Innovative Research Award

Head of Bio-Lab | Hue University | Vietnam

Dr. Phan Vu Hai, currently serving as Head of the Bio-Lab at the Faculty of Animal Science and Veterinary Medicine, University of Agriculture and Forestry, Hue University, Vietnam, is a distinguished veterinary researcher with extensive contributions to animal health and sustainable livestock production. He earned his academic training in veterinary science and advanced specialization in livestock nutrition and health management, which laid the foundation for his pioneering research on indigenous medicinal herbs and probiotic fermentation as alternatives to antibiotics in tropical poultry and livestock systems. His work has significantly advanced strategies to combat antimicrobial resistance while enhancing reproductive performance and disease resistance in farm animals. Dr. Hai has authored more than 50 scientific publications, including over 10 indexed in Scopus Q1/Q2 and Web of Science journals, alongside influential books such as Using Herbs in Veterinary Medicine and Probiotic-Fermented Alliaceae Herbs as an Alternative to Antibiotics in Broiler Chicken, both published with ISBN registration. His contributions have been recognized through leadership of multiple national and provincial research projects funded by the Ministry of Agriculture and Rural Development and Hue University, as well as his consultancy for Greenfeed Vietnam. In addition to research, he has supervised PhD, master’s, and undergraduate students, fostering the next generation of veterinary scientists. Dr. Hai’s achievements have earned him recognition as an innovative researcher in veterinary herbal medicine, poultry nutrition, and sustainable farming practices. He also contributes to the scientific community through collaborations and peer-review roles for veterinary and livestock journals, strengthening both national and global networks in animal health research.

Profiles: Google Scholar | ORCID

Publications

1. Hai, P. V., Anh, L. X., & Hoa, N. X. (2025). Fermented Chive (Allium schoenoprasum) with Lactobacillus plantarum: A potential antibiotic alternative feed additive for broilers challenged with Escherichia coli. Fermentation.

2. Hai, P. V. (2025). Isolation and selection of indigenous chicken-derived Bacillus subtilis strains as potential probiotic alternatives to antibiotics against Gram-negative enteropathogens. Journal of Advanced Veterinary and Animal Research.

3. Hai, P., Hoang, P., Pham, H., Tran, N., Ngo, L., Nguyen, K., Tran, L., & Nguyen, H. (2024). Selection of Lactobacillus strains from native chicken feces for the fermentation of purple onion (Allium cepa L.) as an antibiotic alternative against Salmonella spp. in chickens. Open Veterinary Journal, 14(12), 35.

4. Hai, P. V. (2024). Optimizing fermentation conditions for purple onion (Allium cepa L.) using Bacillus subtilis bsn5 to produce products rich in carboxymethyl cellulase for poultry farming. TNU Journal of Science and Technology.

5. Hai, P. V., & Tran, N. L. (2023). Effects of chive bulb extract on semen quality and blood biochemistry of roosters under heat stress conditions. Proceedings of the 5th Vietnam Animal Husbandry and Veterinary Science Conference (AVS2023).

Hamidreza Aghababaeian | Public Health | Best Researcher Award

Published on by Health Scientists

Dr. Hamidreza Aghababaeian | Public Health | Best Researcher Award

Faculty member at DUMS, Iran

Dr. Hamidreza Aghababaeian is a distinguished health scientist with in healthcare, academia, and disaster-related research. Holding a PhD in Health in Emergencies and Disasters, he has made significant contributions as Dean of the Center for Climate Change and Health Research and through leadership in numerous national projects on climate resilience, disaster preparedness, and environmental health impacts. His extensive publications, systematic reviews, and policy-oriented studies address urgent public health issues such as dust storms, extreme weather, and drought adaptation. As a faculty member, he has trained future professionals in disaster health, research methods, and emergency management, while also serving as an editorial board member and reviewer for leading international journals. His work demonstrates a strong blend of scholarly excellence, societal relevance, and leadership. With potential to expand global collaborations and adopt advanced analytical tools, he is highly deserving of the Best Researcher Award.

Professional Profile 

Google Scholar | Scopus Profile | ORCID Profile 

Education

Dr. Hamidreza Aghababaeian possesses a strong academic foundation in health sciences, beginning with a Bachelor of Science in Nursing from Semnan University of Medical Sciences, Iran, followed by a Master of Science in Medical Surgical Nursing from Ahvaz University of Medical Sciences. He advanced his expertise with a PhD in Health in Emergencies and Disasters from Tehran University of Medical Sciences, focusing on the development of models to assess the health impacts of extreme weather events and dust storms. His academic journey reflects a commitment to integrating clinical knowledge with public health and disaster management, bridging the gap between patient care and large-scale emergency preparedness. Additionally, he has enriched his qualifications through specialized international training, including the Health Emergencies in Large Populations (HELP) course by the International Committee of the Red Cross, Health in Emergencies and Disasters courses, and the European Climate Resilient Health Systems Course, demonstrating dedication to lifelong learning and global expertise.

Experience

Dr. Hamidreza Aghababaeian has extensive professional experience spanning healthcare services, academic leadership, and disaster health research. He has served in health centers and disaster response fields, applying both clinical and strategic expertise. He has been a faculty member at Dezful University of Medical Sciences, teaching courses in health in emergencies and disasters, disaster management, triage, and research methodology. He has held leadership positions as a group manager and as the Dean of the Center for Climate Change and Health Research, where he directed numerous national projects on disaster resilience, climate change impacts, and environmental health risks. His professional contributions extend to scientific publishing as an editorial board member and peer reviewer for prestigious journals. Through a combination of teaching, research, and leadership, Dr. Aghababaeian has significantly advanced the field of disaster health and climate-related public health strategies.

Research Interest

Dr. Hamidreza Aghababaeian’s research interests lie at the intersection of public health, disaster medicine, and climate change, with a strong focus on understanding and mitigating the health impacts of environmental hazards. His work extensively explores extreme weather events, dust storms, heat and cold waves, drought, and their implications for morbidity, mortality, and health system resilience. He is particularly interested in developing models, frameworks, and policy strategies to strengthen healthcare preparedness and community resilience against climate change–induced risks. His research also examines the role of social resilience, sex-based health differences, and adaptation strategies in vulnerable populations, including those with disabilities. Through systematic reviews, meta-analyses, and applied field studies, he aims to translate scientific findings into actionable solutions for policymakers, healthcare providers, and disaster management authorities. Ultimately, his research seeks to bridge the gap between climate science, health systems, and community preparedness to enhance public health resilience at local, national, and global levels.

Award and Honor

Dr. Hamidreza Aghababaeian has earned recognition for his outstanding contributions to health sciences, disaster medicine, and climate change–related public health research. His leadership at the Center for Climate Change and Health Research and his pivotal role in numerous nationally significant projects have positioned him as a leading figure in advancing evidence-based strategies for disaster resilience and health system preparedness. He has been honored through appointments as an editorial board member for the Journal of Advanced Immunopharmacology and as a peer reviewer for prestigious international journals, including Frontiers in Public Health, PLOS One, and the Journal of Disaster Medicine and Public Health Preparedness. These roles reflect the scientific community’s trust in his expertise and scholarly judgment. His achievements also include invitations to participate in specialized international courses and collaborations, underscoring his global reputation. Collectively, these honors highlight his exceptional dedication, professional excellence, and lasting impact on public health and disaster management.

Research Skill

Dr. Hamidreza Aghababaeian possesses advanced research skills encompassing study design, data collection, statistical analysis, and scientific writing, with a particular expertise in public health, disaster medicine, and climate change–related health impacts. He is proficient in conducting systematic reviews, meta-analyses, and policy-oriented research, translating complex scientific evidence into practical strategies for health system resilience. His analytical capabilities are supported by strong command of statistical software such as SPSS and Excel, enabling him to perform detailed epidemiological and environmental health analyses. He has successfully managed multidisciplinary research projects, from conceptualization to dissemination, often involving collaboration with national and international stakeholders. His skill set extends to developing models and preparedness frameworks, designing adaptation strategies for vulnerable populations, and integrating qualitative and quantitative research methods. With extensive experience in peer review and editorial responsibilities, Dr. Aghababaeian demonstrates exceptional ability to critically evaluate scientific work while maintaining high standards of academic rigor and research integrity.

Publications Top Notes

Title: The concept of successful aging: a review article
Authors: F. Estebsari, M. Dastoorpoor, Z.R. Khalifehkandi, A. Nouri, D. Mostafaei
Year: 2020

Title: Air pollution and hospital admissions for cardiovascular diseases in Ahvaz, Iran
Authors: M. Dastoorpoor, Z. Sekhavatpour, K. Masoumi, M.J. Mohammadi
Year: 2019

Title: Global health impacts of dust storms: a systematic review
Authors: H. Aghababaeian, A. Ostadtaghizadeh, A. Ardalan, A. Asgary, M. Akbary
Year: 2021

Title: Alcohol intake in an attempt to fight COVID-19: A medical myth in Iran
Authors: H. Aghababaeian, L. Hamdanieh, A. Ostadtaghizadeh
Year: 2020

Title: The methanol poisoning outbreaks in Iran 2018
Authors: H. Aghababaeian, L. Araghi Ahvazi, A. Ostadtaghizadeh
Year: 2019

Title: Design and implementation of an empowerment model to prevent elder abuse: a randomized controlled trial
Authors: F. Estebsari, M. Dastoorpoor, D. Mostafaei, N. Khanjani, Z.R. Khalifehkandi
Year: 2018

Title: Heat waves and adaptation: A global systematic review
Authors: M. Kiarsi, M. Amiresmaili, M.R. Mahmoodi, H. Farahmandnia, N. Nakhaee
Year: 2023

Title: Lag time structure of cardiovascular deaths attributed to ambient air pollutants in Ahvaz, Iran, 2008–2015
Authors: M. Dastoorpoor, G. Goudarzi, N. Khanjan, E. Idani, H. Aghababaeian
Year: 2018

Conclusion

Based on his extensive academic qualifications, leadership in climate change and health research, prolific contributions to disaster and emergency health literature, and active engagement in scientific peer review, Dr. Hamidreza Aghababaeian is a highly deserving candidate for the Best Researcher Award. His career reflects a strong combination of scholarly excellence, societal impact, and mentorship. With continued focus on expanding international research collaborations and leveraging emerging technologies, he holds great potential to further influence global health resilience strategies and shape the next generation of health scientists.

Ritu Tiwari | Global Health | Best Researcher Award

Published on by Health Scientists

Dr. Ritu Tiwari | Global Health | Best Researcher Award

Scientific Officer at Indian Pharmacopoeia Commission, India

Dr. Ritu Tiwari is a highly accomplished researcher and scientific officer working with the Indian Pharmacopoeia Commission under the Ministry of Health and Family Welfare. Her work focuses on the development, validation, and quality assessment of phytopharmaceuticals, herbal drugs, and traditional formulations. She has made substantial contributions to drafting monographs for the Ayurvedic Pharmacopoeia and advancing analytical methodologies through regulatory and technical leadership. With expertise spanning pharmacognosy, phytochemistry, and analytical science, she has authored numerous impactful research papers in reputed journals and participated in global scientific events. Her active involvement in national committees, assessor roles, and software development projects underlines her dynamic and multidisciplinary capabilities. Her dedication to regulatory improvement and scientific excellence has earned her widespread recognition through national and international awards. She continues to influence health and pharmaceutical policy through her research and technical contributions, making her a compelling candidate for recognition in the field of pharmaceutical and herbal sciences.

Professional Profile

 Scopus Profile

Education

Dr. Ritu Tiwari possesses a unique blend of interdisciplinary academic qualifications that underpin her scientific expertise. She holds postgraduate degrees in botany and computer applications, supplemented by professional education in law and pedagogy. Further advancing her technical proficiency, she has acquired diplomas in chemical instrumentation, industrial hygiene, and software systems. Her doctoral research specialized in phytochemistry and pharmacognosy, equipping her with advanced knowledge in the characterization of plant-based medicinal compounds. This academic foundation has enabled her to understand complex biological systems and regulatory frameworks, integrating science, policy, and technology. Her diverse qualifications reflect a rare integration of natural sciences, legal acumen, and digital competency, supporting her multifaceted role in pharmaceutical standard-setting. Her educational background is not only academically rich but also deeply aligned with her professional responsibilities, making her well-positioned to contribute meaningfully to scientific innovation, regulatory advancement, and interdisciplinary collaboration within national and international health and pharmacological landscapes.

Experience

Dr. Ritu Tiwari has served for decades as a scientific officer with the Indian Pharmacopoeia Commission, where she plays a key role in ensuring the quality and safety of pharmaceuticals. Her responsibilities include the development and validation of testing methods for pharmaceutical products, including herbal and phytopharmaceutical formulations. She has been instrumental in preparing and verifying monographs and general chapters for national pharmacopoeias. Her professional journey reflects a deep engagement with regulatory science, public health, and quality control. She also actively contributes to technical dossier reviews, enabling the inclusion of scientifically backed formulations in official standards. In addition to her core responsibilities, she serves on technical committees and works with digital development teams to enhance pharmacopoeial documentation. Her experience spans laboratory science, method validation, and institutional policy development. Her comprehensive professional involvement reflects her strong commitment to maintaining scientific rigor in drug evaluation and her influence on regulatory systems and health policy.

Research Interest

Dr. Ritu Tiwari’s research interests lie in the fields of pharmacognosy, phytochemistry, and analytical method development, with a strong focus on herbal drug standardization and phytopharmaceuticals. She is particularly passionate about exploring the chemical and biological properties of medicinal plants, applying modern analytical tools such as chromatography and metabolomics to understand bioactive compounds. Her work also includes quality control studies that examine contaminants like pesticides, heavy metals, and aflatoxins in traditional medicines. In addition, she investigates the therapeutic potential of plant-based compounds for inflammatory, metabolic, and microbial disorders. A growing area of interest in her work includes the integration of quality-by-design principles in method development, regulatory science, and evidence-based traditional medicine. Her research is highly relevant to contemporary needs in pharmacological sciences, especially in enhancing the safety, efficacy, and global acceptance of traditional and herbal medicines. She is driven by the goal of bridging ancient knowledge with modern pharmaceutical standards.

Award and Honor

Dr. Ritu Tiwari has been recognized with several prestigious awards for her outstanding contributions to pharmaceutical science and herbal research. She received national acclaim through the Dr. P. D. Sethi Memorial HPTLC Award for excellence in analytical research. Her presentations at international conferences have earned her multiple honors, including best oral and poster presentations, highlighting the quality and impact of her work. She has been acknowledged for her research on bioactive compounds, regulatory science, and phytopharmaceutical development. Her awards span multiple disciplines and events, reflecting recognition from academic, scientific, and regulatory communities. These honors not only celebrate her technical skill and innovation but also emphasize her role in advancing public health through high-quality research. In addition to scientific recognition, her involvement in key conferences and workshops underscores her influence in professional development and knowledge dissemination. Her accolades are a testament to her sustained excellence and respected leadership in her field.

Research Skill

Dr. Ritu Tiwari possesses a broad range of research skills that contribute to her effectiveness as a scientist and technical expert. She is adept in analytical techniques such as high-performance thin-layer chromatography, high-performance liquid chromatography, and nuclear magnetic resonance spectroscopy, which she applies to identify and quantify active compounds in herbal and pharmaceutical products. She has expertise in metabolomic profiling, quality-by-design frameworks, and method validation processes. Her skills extend to pharmacognostic characterization and the evaluation of contaminants like heavy metals and pesticides. She is also experienced in preparing scientific dossiers, regulatory documentation, and pharmacopoeial monographs. Her capacity to integrate traditional knowledge with contemporary scientific methods enables her to contribute meaningfully to the field of phytopharmaceuticals. She has demonstrated strong capabilities in technical writing, scientific presentation, and software-supported data management. These competencies make her not only a highly skilled researcher but also a valuable contributor to national health and pharmacopoeial standards.

Publications Top Notes

Title: Mpox outbreak response: Regulatory and public health perspectives from India and the world
Authors: Ritu Tiwari, et al.
Year: 2025

Conclusion

Dr. Ritu Tiwari stands out as a deeply committed scientific officer, technical expert, and scholar whose contributions have significantly advanced India’s pharmacopoeial standards and phytopharmaceutical research. Her consistent publication output, interdisciplinary qualifications, regulatory insight, and numerous awards position her as an outstanding candidate for the Best Researcher Award. With continued expansion into international collaborations, innovation-led research, and public health policy contributions, she is poised to make even broader contributions to global health science. Therefore, she is highly deserving of this recognition.